A favourable effect of recombinant human erythropoietin in three cases of leukaemic transformation from chronic myelomonocytic leukaemia.
Uziel
L
L
Clinica Medica Università, di Milano Ospedale S. Paolo, Italia.
Fabrizi
I
I
Zighetti
M L
ML
Carpani
G
G
Rosti
A
A
Moroni
G A
GA
Marmont
A
A
D000368:Aged; D001752:Blast Crisis / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000097:blood / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D012156:Reticulocytes / Q000473:pathology
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin